U of U Hospital Clinic 1-A: Comprehensive HIV/AIDS Care for 90% of UtahnsUniversity of Utah Hospital Clinic 1-A provides care for 90% of Utahns with HIV/AIDS and is the only Ryan White-sponsored clinic in the state. Dr. Claudia Goulston and Dr. Harry Rosado-Santos,…
From Interactive Marketing & Web
| 120
120 plays
| 0
April 26, 2017 Interviewer: The University of Utah is home to the only Ryan White-sponsored HIV clinic in Utah, treating up to 90% of Utahan HIV patients. We're joined today by two doctors from the clinic to speak on what that clinic offers. Announcer: Health tips, medical news, research, and more for a happier, healthier life. From University of Utah Health Sciences, this is The Scope. Interviewer: We're sitting down with Dr. Claudia Goulston. She is an Associate Professor in Infectious Diseases, and Dr. Rosado, who is the Medical Program Director for the Ryan White Program. When it comes to HIV and AIDS treatment and diagnosis, and things like that, where does the Ryan White Program fit within the Salt Lake community? Dr. Rosado: So the Ryan White Program, basically, the purpose of this program is to treat people who are HIV infected and are unable to pay for HIV therapy, because the HIV therapy is very expensive even in this country. We also have funding to do HIV testing mainly for partners of our patient, spouses, and anybody who wants to have an HIV test, we can do that using Ryan White funding. Interviewer: So, Dr. Rosado, how many people do you see here in Salt Lake? Dr. Rosado: In the clinic, we had about 1,600, 1,700. It depends. Patients that come to our clinic, not all of them are Ryan White patients because we see people who are Medicare, Medicaid, or they have primary insurance. That's the total of the 1,600 patients. But people who quality for Ryan White is about 500 patients that receive Ryan White funding. Interviewer: And Dr. Goulston, why is a program like this important for a population like this? Dr. Goulston: Well, many people are uninsured or underinsured, as the case may be, and so it kind of dovetails with that. And we have all sorts of providers within the clinic that work as a medical home to help get patients care. So we have case managers that can help treat patients and get them into care. We have counselors, psychiatrists, OB-GYN, neurology in our clinic as well and we work with all these different subspecialties to try and give them the best care possible. Interviewer: So that sounds like a pretty comprehensive care. So that's at Clinic 1A? Is that important for the treatment? It's not just medication, it's everything else? Dr. Rosado: Well, again, we offer a comprehensive HIV care to our patients and we try, as Dr. Goulston mentioned, to have a medical home model so the patient can come to that clinic and they can see the HIV provider. If they need to see psychiatric care, mental health, neurology, or OB-GYN, we have all those services in the clinic. Interviewer: I mean, programs like Ryan White where you can get these new treatments and things, it . . . I mean, treatment is not like it was 20, 30 years ago, right? Dr. Goulston: Not at all. Interviewer: How has it changed? Dr. Goulston: Well, now, we have many regimens that are single-drug or single-tablet regimens once a day. We have much lower side effects and very effective, and it is much more tolerable for patients to take and to remember. We used to have treatments that could be up to five times a day with miserable side effects, and those days are gone. Interviewer: So it's not a death sentence anymore either, right? Dr. Goulston: If you take your meds and can afford them and can carry through, then people can live. Interviewer: So Clinic 1A . . . So it's treatment. Do they offer services for prevention? Dr. Rosado: We do. In Clinic 1A, we do offer clinic services for prevention. But we need to emphasize here that the Ryan White Program doesn't pay for TRUVADA for prevention or HIV PrEP, because the funding for Ryan White is for people who are HIV infected. But we do see patients that are taking PrEP, TRUVADA, to prevent HIV. Usually, these people have their own insurance. And the company that makes TRUVADA, Gilead, they do have a patient assistant program. If a patient is unable to pay for the medication, they can offer the medication for free as long as the patient qualifies. Interviewer: So say a listener who might be HIV-positive, underinsured, or not even have insurance, where they can go get more information for the Ryan White Program? Dr. Rosado: Now, these people can go online and Google "Ryan White" and they will get all the information they need. In Utah, they can call the University Hospital Clinic 1A and we can offer them more information about Ryan White. We see anybody who wants to come to the clinic, and I need to mention, including people who are undocumented. As long as they are a Utah resident, they qualify for the Ryan White. And the reason I say this is Ryan White is present in every single state. The only qualification will be that you have HIV and you reside in that specific state, and you are unable to pay for your medication. The Ryan White, definitely, will cover your HIV therapy. Announcer: Want The Scope delivered straight to your inbox? Enter your email address at thescoperadio.com and click "Sign Me Up" for updates of our latest episodes. The Scope Radio is a production of University of Utah Health Sciences. |
|
HIV/AIDS Care: PrEPPre-exposure prophylaxis (PrEP) is a relatively new treatment for at-risk patients that can reduce the chances of an individual contracting HIV by more than 90 percent. However, it should not be seen…
From Interactive Marketing & Web
| 51
51 plays
| 0
April 10, 2017 Interviewer: New FDA approved oral medication that has been shown to prevent transmission of HIV, we're talking about PrEP today on The Scope. Announcer: Health tips, medical news, research, and more for a happier, healthier life. From University of Utah Health Sciences, this is The Scope. Interviewer: We're here with Dr. Claudia Goulston. She is the associate professor in infectious diseases, and she is a HIV specialist. When it comes to HIV, prevention is huge, right? Dr. Goulston: Correct. Interviewer: Because I've been hearing that it's what, 40,000 new cases in America each year? Dr. Goulston: That's the ones that are known. Interviewer: Why did you specify that? Are there tons that aren't known? Dr. Goulston: Potentially, there's a lot more than that. They actually estimate around 50,000 at least. Interviewer: And that number doesn't seem to be changing. Why is that? Dr. Goulston: No. Because even though we prevent cases, some people are not on medications and some people also don't know that they're HIV positive, and so their risk is high and spreading it to other people. Interviewer: When it comes to prevention, what is the tried and true best way to prevent infection? Dr. Goulston: Condoms, first. Interviewer: Is it that simple? Dr. Goulston: It's that simple. But there's also PrEP, which is pre-exposure prophylaxis, which is with a medication that they can take called TRUVADA, and that helps prevent cases in people who engage in higher risk behaviors. Interviewer: I've seen down at the Pride Center and stuff, there's posters and stuff about PrEP. What is PrEP exactly? How does it prevent? It sounds like it's a full blown vaccine, but . . . Dr. Goulston: No. It's a medication that you have to take every day and it prevents you from getting HIV if you engage in sex or exchange blood with someone who has HIV. Interviewer: Now, is it expensive? Dr. Goulston: It's extremely expensive. It's about $1,700 a month. Interviewer: Wow, and is that just because it's new? Is that because . . . Dr. Goulston: No. That's the cost. It's not new. Interviewer: So it might be a little easier to just . . . Dr. Goulston: It's part of the cocktail that we give patients when they have HIV. Interviewer: It's the same cocktail that you give after the infection, but it helps prevent it? Dr. Goulston: Correct. Interviewer: What are some of the side effects of PrEP? Dr. Goulston: First, you have to have to not be HIV positive to begin with. We screen patients for that. It can also treat hepatitis B, which is one of the good things about it. But as far as side effects, it can cause renal toxicity which is kidneys, and it can also cause osteoporosis or thinning of the bones. Interviewer: Are those side effects pretty common? Are those . . . Dr. Goulston: The thinning of the bones takes a while and the kidney dysfunction can occur in not the majority, but in some patients it can occur. Interviewer: This isn't necessarily . . . It's not 100% prevention? Dr. Goulston: No. Interviewer: What are the rates of prevention? Dr. Goulston: It's supposed to be helpful in up to 90% if you take it. But if you don't take it, it doesn't work, number one. Then if you have someone who has a more resistant virus and they are the person who's infecting you, there has been one case of transmission in someone who is taking PrEP and was documented to actually be taking it at the time that they were infected, but they got it from someone who had a resistant virus. Interviewer: What kind of patient is PrEP good for? Dr. Goulston: Anyone who has multiple partners. It would be a good person or someone who is monogamous with a partner who is HIV infected, that would be a good one, or someone who is in a partnership and they want to get pregnant, and one of the couple is positive and the other one is negative. Interviewer: After talking about prevention and PrEP, if there is someone who is wondering about it or might be engaging in some of these behaviors that might expose them to HIV, what is the one take-away message you would have for them? Dr. Goulston: That PrEP is effective and it can reduce the risk for HIV by at least 90%, and that they should come in if they're so interested, and we can help them. Announcer: Want The Scope delivered straight to your inbox? Enter your email address at thescoperadio.com and click "Sign Me Up" for updates of our latest episodes. The Scope Radio is a production of University of Utah Health Sciences. |